191 related articles for article (PubMed ID: 30623563)
1. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes.
Jones KL; Rigda RS; Buttfield MDM; Hatzinikolas S; Pham HT; Marathe CS; Wu T; Lange K; Trahair LG; Rayner CK; Horowitz M
Diabetes Obes Metab; 2019 May; 21(5):1158-1167. PubMed ID: 30623563
[TBL] [Abstract][Full Text] [Related]
2. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial.
Rayner CK; Watson LE; Phillips LK; Lange K; Bound MJ; Grivell J; Wu T; Jones KL; Horowitz M; Ferrannini E; Tricò D; Frascerra S; Mari A; Natali A
Diabetes Care; 2020 Aug; 43(8):1813-1821. PubMed ID: 32471908
[TBL] [Abstract][Full Text] [Related]
3. Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes.
Trahair LG; Horowitz M; Stevens JE; Feinle-Bisset C; Standfield S; Piscitelli D; Rayner CK; Deane AM; Jones KL
Diabetologia; 2015 Aug; 58(8):1769-78. PubMed ID: 26048234
[TBL] [Abstract][Full Text] [Related]
4. The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial.
Juel CTB; Lund A; Andersen MM; Hansen CP; Storkholm JH; Rehfeld JF; van Hall G; Hartmann B; Wewer Albrechtsen NJ; Holst JJ; Vilsbøll T; Knop FK
Diabetologia; 2020 Jul; 63(7):1285-1298. PubMed ID: 32394228
[TBL] [Abstract][Full Text] [Related]
5. Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia.
Lorenz M; Pfeiffer C; Steinsträsser A; Becker RH; Rütten H; Ruus P; Horowitz M
Regul Pept; 2013 Aug; 185():1-8. PubMed ID: 23665027
[TBL] [Abstract][Full Text] [Related]
6. Metformin attenuates the postprandial fall in blood pressure in type 2 diabetes.
Borg MJ; Jones KL; Sun Z; Horowitz M; Rayner CK; Wu T
Diabetes Obes Metab; 2019 May; 21(5):1251-1254. PubMed ID: 30615231
[TBL] [Abstract][Full Text] [Related]
7. The Effects of a Whey Protein and Guar Gum-Containing Preload on Gastric Emptying, Glycaemia, Small Intestinal Absorption and Blood Pressure in Healthy Older Subjects.
Pham H; Holen IS; Phillips LK; Hatzinikolas S; Huynh LQ; Wu T; Hausken T; Rayner CK; Horowitz M; Jones KL
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694157
[TBL] [Abstract][Full Text] [Related]
8. Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes--a study in both people with type 2 diabetes and healthy subjects.
Becker RH; Stechl J; Msihid J; Kapitza C
Diabetes Obes Metab; 2014 Sep; 16(9):793-800. PubMed ID: 24521245
[TBL] [Abstract][Full Text] [Related]
9. Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance.
Whyte MB; Shojaee-Moradie F; Sharaf SE; Jackson NC; Fielding B; Hovorka R; Mendis J; Russell-Jones D; Umpleby AM
J Clin Endocrinol Metab; 2019 Feb; 104(2):359-368. PubMed ID: 30215735
[TBL] [Abstract][Full Text] [Related]
10. Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric Emptying.
Marathe CS; Pham H; Wu T; Trahair LG; Rigda RS; Buttfield MDM; Hatzinikolas S; Lange K; Rayner CK; Mari A; Horowitz M; Jones KL
Diabetes Ther; 2022 Jun; 13(6):1245-1249. PubMed ID: 35460043
[TBL] [Abstract][Full Text] [Related]
11. Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying--preclinical evidence.
Werner U
J Diabetes Complications; 2014; 28(1):110-4. PubMed ID: 23992745
[TBL] [Abstract][Full Text] [Related]
12. Effects of sitagliptin on gastric emptying of, and the glycaemic and blood pressure responses to, a carbohydrate meal in type 2 diabetes.
Stevens JE; Buttfield M; Wu T; Hatzinikolas S; Pham H; Lange K; Rayner CK; Horowitz M; Jones KL
Diabetes Obes Metab; 2020 Jan; 22(1):51-58. PubMed ID: 31468664
[TBL] [Abstract][Full Text] [Related]
13. Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects.
Becker RH; Stechl J; Steinstraesser A; Golor G; Pellissier F
Diabetes Metab Res Rev; 2015 Sep; 31(6):610-8. PubMed ID: 25773712
[TBL] [Abstract][Full Text] [Related]
14. Effects of glucagon-like peptide-1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study.
Kuwata H; Yabe D; Murotani K; Fujiwara Y; Haraguchi T; Kubota S; Kubota-Okamoto S; Usui R; Ishitobi M; Yamazaki Y; Hamamoto Y; Kurose T; Seino Y; Yamada Y; Seino Y
J Diabetes Investig; 2021 Dec; 12(12):2162-2171. PubMed ID: 34022121
[TBL] [Abstract][Full Text] [Related]
15. Acute Effects of Lixisenatide on Energy Intake in Healthy Subjects and Patients with Type 2 Diabetes: Relationship to Gastric Emptying and Intragastric Distribution.
Jalleh R; Pham H; Marathe CS; Wu T; Buttfield MD; Hatzinikolas S; Malbert CH; Rigda RS; Lange K; Trahair LG; Feinle-Bisset C; Rayner CK; Horowitz M; Jones KL
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630191
[TBL] [Abstract][Full Text] [Related]
16. Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials.
Ahrén B; Gautier JF; Berria R; Stager W; Aronson R; Bailey CJ
Diabetes Obes Metab; 2014 Sep; 16(9):861-8. PubMed ID: 24641271
[TBL] [Abstract][Full Text] [Related]
17. Lixisenatide Versus Insulin Glulisine on Fasting and Postbreakfast Systemic Hemodynamics in Type 2 Diabetes Mellitus Patients.
Tonneijck L; Muskiet MHA; Twisk JW; Kramer MHH; Danser AHJ; Joles JA; Smits MM; van Raalte DH
Hypertension; 2018 Aug; 72(2):314-322. PubMed ID: 29915021
[TBL] [Abstract][Full Text] [Related]
18. Effects of intragastric administration of L-tryptophan on the glycaemic response to a nutrient drink in men with type 2 diabetes - impacts on gastric emptying, glucoregulatory hormones and glucose absorption.
Hajishafiee M; Elovaris RA; Jones KL; Heilbronn LK; Horowitz M; Poppitt SD; Feinle-Bisset C
Nutr Diabetes; 2021 Jan; 11(1):3. PubMed ID: 33414406
[TBL] [Abstract][Full Text] [Related]
19. A randomized, crossover study of the acute effects of acarbose and gastric distension, alone and combined, on postprandial blood pressure in healthy older adults.
Pham H; Trahair L; Phillips L; Rayner C; Horowitz M; Jones K
BMC Geriatr; 2019 Aug; 19(1):241. PubMed ID: 31470806
[TBL] [Abstract][Full Text] [Related]
20. Intragastric administration of leucine and isoleucine does not reduce the glycaemic response to, or slow gastric emptying of, a carbohydrate-containing drink in type 2 diabetes.
Elovaris RA; Hajishafiee M; Ullrich SS; Fitzgerald PCE; Lange K; Horowitz M; Feinle-Bisset C
Diabetes Res Clin Pract; 2021 Jan; 171():108618. PubMed ID: 33310174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
